Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease

THURSDAY, April 11, 2024 -- Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news